AbbVie Inc
(FRA:4AB)
€
218
+4.5 (+2.11%)
Market Cap: 393.99 Bil
Enterprise Value: 449.89 Bil
PE Ratio: 124.80
PB Ratio: 0
GF Score: 82/100 Abbvie Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2020 / 07:40PM GMT
Release Date Price:
€86.8
(-0.34%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI biotech team and pleased to welcome from AbbVie, we have Mike Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer; Jeff Stewart, President of U.S. Commercial Operations. Wonderful to have you, gentlemen, here. Thanks for joining us.
Questions & Answers
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
Looking at some of the item script trajectories for RINVOQ and SKYRIZI, it's hard to tell we're in a pandemic. Really, incredible launches. Maybe you can talk and kick things off talking a little bit about the pushes and pulls of these launches in a pandemic and where the headwinds are and tailwinds.
Michael E. Severino
AbbVie Inc. - Vice Chairman & President
Sure. I'll start, and then Rob and Jeff may want to
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot